Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Argus Health
Johnson and Johnson
Baxter
Federal Trade Commission
Chubb
Boehringer Ingelheim
Queensland Health
AstraZeneca

Generated: July 16, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: canagliflozin

« Back to Dashboard

Canagliflozin

CASRN: 842133-18-0UNII:

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Teva
Farmers Insurance
Chubb
Deloitte
Johnson and Johnson
Fish and Richardson
Chinese Patent Office
US Department of Justice